Dr. Yu’s research interests include noncoding RNA controlled regulatory mechanisms, anticancer pharmacology and experimental therapeutics. The ultimate goal of his research is to translate noncoding RNAs into new therapies. Current efforts in his laboratory are directed to the investigation of (a) novel RNA bioengineering technologies, (b) actions of microRNAs in the regulation of cancer cellular processes including drug/xenobiotic disposition and tumor progression and metastasis, (c) RNA therapeutics, and (d) PK/PD modeling.

Accepting students per funding availability.